This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Philip Lustenberger: Innovator in Alkyne Compounds
Introduction
Philip Lustenberger is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his work on alkyne compounds. His innovative approach has led to advancements in the treatment of various metabolic and eating disorders.
Latest Patents
Lustenberger holds a patent for "Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds." This invention relates to alkyne compounds of a specific general formula, which are designed to exhibit MCH-receptor antagonistic activity. The pharmaceutical compositions derived from these compounds are particularly suitable for treating conditions such as obesity, bulimia, anorexia, hyperphagia, and diabetes. He has 1 patent to his name.
Career Highlights
Philip Lustenberger is associated with Boehringer Ingelheim Pharma GmbH & Co. KG, a leading global pharmaceutical company. His work at Boehringer Ingelheim has allowed him to focus on developing innovative solutions for complex health issues. His research has the potential to impact the lives of many individuals suffering from metabolic disorders.
Collaborations
Lustenberger has collaborated with esteemed colleagues, including Dirk Stenkamp and Stephan Georg Mueller. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Philip Lustenberger's contributions to the field of medicinal chemistry, particularly through his patent on alkyne compounds, highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for new treatments for metabolic and eating disorders.